Literature DB >> 19932269

How good is a good Fontan? Quality of life and exercise capacity of Fontans without arrhythmias.

Yves d'Udekem1, Michael M H Cheung, Stella Setyapranata, Ajay J Iyengar, Patricia Kelly, Naomi Buckland, Leeanne E Grigg, Robert G Weintraub, Alasdair Vance, Christian P Brizard, Dan J Penny.   

Abstract

BACKGROUND: Poor long-term outcomes are expected after Fontan surgery, but these perspectives have been tainted by the poorly functioning Fontans suffering from arrhythmias. No predictions of outcome can be quoted to the increasing number of Fontan patients free from arrhythmic complications. The parameters determining improved exercise capacity and quality of life in this subgroup are yet unknown.
METHODS: Fontan survivors from our institution and living in Victoria were invited to participate in the study if they were more than 10 years of age, and free of arrhythmias. A mean of 17 +/- 4 years after Fontan, 36 patients, 23 with a classical atriopulmonary connection (AP) and 13 with a lateral tunnel (LT) underwent transthoracic echocardiography, cycloergometer exercise study, neurohumoral screening, and assessment of quality of life.
RESULTS: The only factor predicting worse exercise capacity was the type of Fontan performed; patients with LT having better exercise capacity than those with AP (percentage of predicted anaerobic threshold: 88 +/- 14% vs 72 +/- 14%, p < 0.005; percentage of predicted VO(2)max: 62 +/- 8% vs 54 +/- 7%, p < 0.005). Endothelin-1 levels were elevated in all patients (2.9 pmol/L, 2.5 to 3.7). Responses from the quality of life measures placed our Fontan cohort mainly within the normal population range. None of the preoperative and postoperative variables adversely affected patients' quality of life.
CONCLUSIONS: The anaerobic threshold of arrhythmia-free Fontan patients operated with the lateral tunnel technique was relatively preserved. Despite restricted exercise capacity, Fontan patients, provided that they are free of arrhythmias, have a normal quality of life reflected in their reports of psychiatric symptoms and family relationships.

Entities:  

Mesh:

Year:  2009        PMID: 19932269     DOI: 10.1016/j.athoracsur.2009.07.079

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  16 in total

1.  Percutaneous liver biopsy in Fontan patients.

Authors:  Abhay Srinivasan; Anthony K Guzman; Elizabeth B Rand; Jack Rychik; David J Goldberg; Pierre A Russo; Anne Marie Cahill
Journal:  Pediatr Radiol       Date:  2018-11-30

2.  Health-related quality of life in paediatric patients with congenital heart defects: association with the type of heart defect and the surgical technique.

Authors:  A Heusch; H J Kahl; K O Hensel; G Calaminus
Journal:  Qual Life Res       Date:  2017-07-20       Impact factor: 4.147

3.  Clinical Profile and Quality of Life of Adult Patients After the Fontan Procedure.

Authors:  Giulia Bordin; Massimo Antonio Padalino; Sonja Perentaler; Biagio Castaldi; Nicola Maschietto; Pierantonio Michieli; Roberto Crepaz; Anna Chiara Frigo; Vladimiro Lorenzo Vida; Ornella Milanesi
Journal:  Pediatr Cardiol       Date:  2015-04-02       Impact factor: 1.655

4.  Quality of life, health status, and depression: comparison between adolescents and adults after the Fontan procedure with healthy counterparts.

Authors:  Nancy A Pike; Lorraine S Evangelista; Lynn V Doering; Jo-Ann Eastwood; Alan B Lewis; John S Child
Journal:  J Cardiovasc Nurs       Date:  2012 Nov-Dec       Impact factor: 2.083

Review 5.  Four decades of Fontan palliation.

Authors:  Marc R de Leval; John E Deanfield
Journal:  Nat Rev Cardiol       Date:  2010-06-29       Impact factor: 32.419

Review 6.  Current Therapy for Hypoplastic Left Heart Syndrome and Related Single Ventricle Lesions.

Authors:  Richard G Ohye; Dietmar Schranz; Yves D'Udekem
Journal:  Circulation       Date:  2016-10-25       Impact factor: 29.690

7.  Association of Habitual Activity and Body Mass Index in Survivors of Congenital Heart Surgery: A Study of Children and Adolescents With Tetralogy of Fallot, Transposition of the Great Arteries, and Fontan Palliation.

Authors:  Michael L O'Byrne; Michael G McBride; Stephen Paridon; Elizabeth Goldmuntz
Journal:  World J Pediatr Congenit Heart Surg       Date:  2018-03

8.  Efficacy of Bosentan in patients after Fontan procedures: a double-blind, randomized controlled trial.

Authors:  Xiao-Ke Shang; Rong Lu; Xi Zhang; Chang-Dong Zhang; Shu-Na Xiao; Mei Liu; Bin Wang; Nian-Guo Dong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28

Review 9.  Computational modeling of Fontan physiology: at the crossroads of pediatric cardiology and biomedical engineering.

Authors:  Timothy C Slesnick; Ajit P Yoganathan
Journal:  Int J Cardiovasc Imaging       Date:  2014-06-05       Impact factor: 2.357

10.  Effectiveness of Bidirectional Glenn Shunt Placement for Palliation in Complex Congenitally Corrected Transposed Great Arteries.

Authors:  Kai Ma; Lei Qi; Zhongdong Hua; Keming Yang; Hao Zhang; Shoujun Li; Sen Zhang; Fengpu He; Guanxi Wang
Journal:  Tex Heart Inst J       Date:  2020-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.